AMLX vs. KTOS
AMLX (Amylyx Pharmaceuticals, Inc.) and KTOS (Kratos Defense & Security Solutions, Inc.) are both stocks. AMLX operates in Biotechnology (Healthcare), while KTOS operates in Aerospace & Defense (Industrials). Over the past 3 years, AMLX returned -4.58%/yr vs 45.72%/yr for KTOS. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
AMLX vs. KTOS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMLX achieves a 68.13% return, which is significantly higher than KTOS's -38.61% return.
AMLX
- 1D
- -2.12%
- 1M
- 11.17%
- 6M
- 42.13%
- YTD
- 68.13%
- 1Y
- 163.25%
- 3Y*
- -4.58%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -0.73%
KTOS
- 1D
- 0.93%
- 1M
- -15.81%
- 6M
- -54.76%
- YTD
- -38.61%
- 1Y
- -17.83%
- 3Y*
- 45.72%
- 5Y*
- 11.37%
- 10Y*
- 26.65%
- ALL TIME*
- -4.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $41.59M | $31.68M | $25.94M | |
| $144.82M | $177.61M | $257.63M |
AMLX vs. KTOS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
AMLX Amylyx Pharmaceuticals, Inc. | 68.13% | 219.58% | -74.32% | -60.16% | 75.95% |
KTOS Kratos Defense & Security Solutions, Inc. | -38.61% | 187.76% | 30.01% | 96.61% | -44.58% |
Correlation
The correlation between AMLX and KTOS is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2022 | 0.21 |
Fundamentals
AMLX:
$2.26B
KTOS:
$8.74B
AMLX:
-$1.51
KTOS:
$0.17
AMLX:
8.22
KTOS:
2.45
AMLX:
$0.00
KTOS:
$1.42B
AMLX:
-$20.10M
KTOS:
$259.40M
AMLX:
-$150.30M
KTOS:
$78.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMLX vs. KTOS — Risk / Return Rank
AMLX
KTOS
AMLX vs. KTOS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amylyx Pharmaceuticals, Inc. (AMLX) and Kratos Defense & Security Solutions, Inc. (KTOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMLX | KTOS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.80 | ||
| Sortino ratioReturn per unit of downside risk | +3.02 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.01 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 5.03 | -0.31 | +5.34 |
| Martin ratioReturn relative to average drawdown | 10.76 | -0.55 | +11.31 |
Loading charts...
Drawdowns
AMLX vs. KTOS - Drawdown Comparison
The maximum AMLX drawdown since its inception was -96.04%, roughly equal to the maximum KTOS drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for AMLX and KTOS.
Loading charts...
Drawdown Indicators
| AMLX | KTOS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.04% | -99.81% | +3.77% |
Max Drawdown (1Y)Largest decline over 1 year | -30.61% | -66.43% | +35.82% |
Max Drawdown (3Y)Largest decline over 3 years | -92.80% | -66.43% | -26.37% |
Max Drawdown (5Y)Largest decline over 5 years | — | -66.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -72.74% | — |
Current DrawdownCurrent decline from peak | -50.38% | -97.05% | +46.67% |
Average DrawdownAverage peak-to-trough decline | -59.30% | -95.93% | +36.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.27% | 37.39% | -23.12% |
Volatility
AMLX vs. KTOS - Volatility Comparison
The current volatility for Amylyx Pharmaceuticals, Inc. (AMLX) is 15.49%, while Kratos Defense & Security Solutions, Inc. (KTOS) has a volatility of 19.73%. This indicates that AMLX experiences smaller price fluctuations and is considered to be less risky than KTOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMLX | KTOS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.49% | 19.73% | -4.24% |
Volatility (6M)Calculated over the trailing 6-month period | 39.64% | 54.32% | -14.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.22% | 71.54% | -10.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.71% | 53.11% | +37.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.71% | 51.16% | +39.55% |
Dividends
AMLX vs. KTOS - Dividend Comparison
Neither AMLX nor KTOS has paid dividends to shareholders.
Financials
AMLX vs. KTOS - Financials Comparison
This section allows you to compare key financial metrics between Amylyx Pharmaceuticals, Inc. and Kratos Defense & Security Solutions, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AMLX and KTOS have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KTOS has higher volatility (19.73%) compared to AMLX (15.49%). In terms of maximum drawdown, AMLX dropped -96.04% vs KTOS's -99.81%.
AMLX currently has the higher Sharpe Ratio (2.51 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMLX and KTOS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer